Latest news
VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMTVeraxa Biotech AG Ord Shs (VRXA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 16:49:17 GMTVERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - BenzingaBenzinga · Thu, 06 Aug 2026 16:27:24 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:20 GMTVRXA: Veraxa Biotech AG - Comparative Chart - Zacks Investment ResearchZacks Investment Research · Sun, 02 Aug 2026 23:35:47 GMTVeraxa Biotech Holding AG - Files To Register Resale Of Up To 25 Million Ordinary Shares - SEC Filing - TradingViewTradingView · Fri, 31 Jul 2026 21:19:46 GMTVeraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms - Stock TitanStock Titan · Fri, 31 Jul 2026 20:05:41 GMTVERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing Bi - BenzingaBenzinga · Thu, 30 Jul 2026 17:04:40 GMT